Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for multiple sclerosis

H L Weiner1, M J Hohol, S J Khoury

  • 1Multiple Sclerosis Unit, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Neurologic Clinics
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis.

Genes and immunity·2011
Same author

A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility.

Genes and immunity·2011
Same author

HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

Neurology·2010
Same author

A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.

Journal of neuroimmunology·2010
Same author

A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis.

Genes and immunity·2010
Same author

CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial.

Neurology·2008

Multiple sclerosis is a cell-mediated autoimmune disease targeting central nervous system myelin. Treatments aim to reduce the immune response and manage symptoms to slow disability progression.

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases

Background:

  • Multiple sclerosis (MS) is widely hypothesized to be an autoimmune condition.
  • The immune system mistakenly attacks the myelin sheath in the central nervous system (CNS).

Purpose of the Study:

  • To outline the autoimmune basis of multiple sclerosis.
  • To discuss current and potential therapeutic strategies for MS.

Main Methods:

  • Review of existing research on MS pathogenesis.
  • Analysis of immunomodulatory and symptomatic treatment approaches.

Main Results:

  • Evidence supports a cell-mediated autoimmune mechanism in MS.
  • Immunotherapy aims to modulate the immune response to halt disease progression.

Related Experiment Videos

  • Symptomatic treatments can improve patient quality of life.

    • Conclusions:

    • Multiple sclerosis is characterized by an autoimmune attack on CNS myelin.
    • Therapeutic strategies focus on immune modulation and symptom management to mitigate disability accumulation.